In #endoscopes Market owing to a greater increase in medical complications in the future and preference for minimally invasive treatment is expected to contribute to the CAGR of 8.5% during the forecast period https://t.co/M7dF9dEgZv
#GIendoscopy#colonoscopy#liverbiopsy
#Asthma among countries like Australia, UK, Netherlands & India collectively account for more than 20% of patient population. While the #COPD burden is prevalent among low- and middle- income countries where air pollution is considerably high. https://t.co/Eb4NtHWEwM
#inhalers
The #Bone#Fixation#Devices Market was valued at US $7.68 billion in the year 2018 and is estimated to reach US $13.11 billion by 2027, at a CAGR of 6.12% https://t.co/T1LWipuXN8
Increasing injury-prone geriatric and diabetes populations are also considered as major market drivers to the #Hemostasis And #Tissue#Sealing Agents market. https://t.co/JCQAt5agdf
According to WHO, the global presence of chronic respiratory conditions is 20.8% in rural and 19.4% in the urban areas. An increase in the prevalence of respiratory conditions increases the demand for #medical#gas and #equipment supply. https://t.co/bT34mykogR
Advancement in R&D activities leading to the development of new class of antibiotics may impact the global #sinusitis market to cross US $3.7 billion by 2026, at a CAGR of 8.68%.https://t.co/vJbAOLgRii
#ChronicPain#Antihistamines#Choronicdisease#sinus
The developing rates of #chronic#diseases that drive the requirement for safeguarding umbilical cord blood stem cells are additionally driving the #cell#therapy market. https://t.co/WKf3hqDOIR
Itโs been a hard, but very fruitful year that brought good experience to all of us. I hope you also find our partnership very effective and look forward to further working relationship.
#newyearsresolution#Happynewyears#GrowthIsLife #NewYear2020#positive#newchallenges
According to the World #Allergy Organization, over 400 million people suffer from allergic rhinitis worldwide. Over 7.8% of people over 18 years of age and around 50 million people in the U.S. suffer from #allergic#rhinitis.
https://t.co/PwpI6wquPH
Obesity treatment is developing as a lucrative opportunity US$14.66 billion by 2026, at a CAGR of 12.92% during the forecast period. #obese#obesityepidemic#Treatingobesity